Neoadjuvant accelerated MVAC (AMVAC) in patients with muscle invasive bladder cancer: Results of a multicenter phase II study

被引：0
|
作者：
Plimack, Elizabeth R.
Hoffman-Censits, Jean H.
Viterbo, Rosalia
Greenberg, Richard Evan
Chen, David
Lallas, Costas D.
Trabulsi, Edouard John
Wong, Yu-Ning
Kutikov, Alexander
Lin, Jianqing
Duncan, Gail
Adair, Beth
Cione, Charlotte
O'Sullivan, Conor
Kilpatrick, Deborah
Ross, Eric A.
Boorjian, Stephen A.
Uzzo, Robert G.
Kelly, William Kevin
Hudes, Gary R.
机构：
[1] Fox Chase Canc Ctr, Philadelphia, PA 19111 USA
[2] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
[3] Mayo Clin, Rochester, MN USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4526
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Long-term results of a phase II study of synchronous chemoradiotherapy in advanced muscle invasive bladder cancer
    Hussain, SA
    Stocken, DD
    Peake, DR
    Glaholm, JG
    Zarkar, A
    Wallace, DMA
    James, ND
    BRITISH JOURNAL OF CANCER, 2004, 90 (11) : 2106 - 2111
  • [42] TRENDS IN NEOADJUVANT CHEMOTHERAPY USE AND ONCOLOGICAL OUTCOMES FOR MUSCLE-INVASIVE BLADDER CANCER IN JAPAN: A MULTICENTER STUDY
    Anan, Go
    Hatakeyama, Shingo
    Fujita, Naoki
    Iwamura, Hiromichi
    Tanaka, Toshikazu
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ito, Hiroyuki
    Yoshikawa, Kazuaki
    Kawaguchi, Toshiaki
    Sato, Makoto
    Ohyama, Chikara
    JOURNAL OF UROLOGY, 2018, 199 (04): : E1036 - E1037
  • [43] Trends in neoadjuvant chemotherapy use and oncological outcomes for muscle-invasive bladder cancer in Japan: a multicenter study
    Anan, Go
    Hatakeyama, Shingo
    Fujita, Naoki
    Iwamura, Hiromichi
    Tanaka, Toshikazu
    Yamamoto, Hayato
    Tobisawa, Yuki
    Yoneyama, Tohru
    Yoneyama, Takahiro
    Hashimoto, Yasuhiro
    Koie, Takuya
    Ito, Hiroyuki
    Yoshikawa, Kazuaki
    Kawaguchi, Toshiaki
    Sato, Makoto
    Ohyama, Chikara
    ONCOTARGET, 2017, 8 (49) : 86130 - 86142
  • [44] Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)
    Nieves Martinez Chanza
    Louisa Soukane
    Philippe Barthelemy
    Aurélien Carnot
    Thierry Gil
    Vinciane Casert
    Vincent Vanhaudenarde
    Brieuc Sautois
    Lionel Staudacher
    Jan Van den Brande
    Stephane Culine
    Emmanuel Seront
    Marco Gizzi
    Simone Albisinni
    Thibault Tricard
    Jean Christophe Fantoni
    Marianne Paesmans
    Rafael Caparica
    Thierry Roumeguere
    Ahmad Awada
    BMC Cancer, 21
  • [45] Neoadjuvant Therapy in Muscle-Invasive Bladder Cancer A Model for Rational Accelerated Drug Development
    Balar, Arjun V.
    Milowsky, Matthew I.
    UROLOGIC CLINICS OF NORTH AMERICA, 2015, 42 (02) : 217 - +
  • [46] A prospective multicenter study of visual response-evaluation by cystoscopy in patients undergoing neoadjuvant chemotherapy for muscle invasive urinary bladder cancer
    Asad, Danna
    Styrke, Johan
    Hagsheno, Mohammad
    Johansson, Markus
    Huge, Ylva
    Svensson, Johan
    Pelander, Sofia
    Lauer, Jan
    Netterling, Hans
    Aljabery, Firas
    Sherif, Amir
    SCANDINAVIAN JOURNAL OF UROLOGY, 2022, 56 (01) : 20 - 26
  • [47] Neoadjuvant Phase II Studies of Modified Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Cancer
    Adesunloye, Bamidele A.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (36) : 4170 - U405
  • [48] Phase II study of concurrent chemoradiotherapy (CCRth) for bladder preservation in the treatment of muscle invasive bladder cancer
    El Taher, A. Mohamed
    Mekawy, M.
    Eid, S. Shehata
    Mostafa, H. G. El Din
    Aziz, A. M. Abdel
    Kamel, Y. Mostafa
    EJC SUPPLEMENTS, 2007, 5 (04): : 310 - 310
  • [49] Multicenter prospective phase II trial of neoadjuvant (neo) dose dense gemcitabine and cisplatin (DD-GC) in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Milowsky, Matthew I.
    Huang, William C.
    Woods, Michael
    Donat, S. Machele
    Herr, Harry W.
    Dalbagni, Guido
    Bochner, Bernard H.
    Ostrovnaya, Irina
    Al-Ahmadie, Hikmat
    Rose, Tracy Lynn
    Riches, Jamie Cathleen
    Kania, Brooke Elizabeth
    Regazzi, Ashley Marie
    Mccoy, Asia S.
    Delbeau, Daniela
    Rosenberg, Jonathan E.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (02)
  • [50] Phase II trial of neoadjuvant gemcitabine (G) and cisplatin (C) with sunitinib in patients (pts) with muscle-invasive bladder cancer (MIBC)
    Balar, Arjun Vasant
    Iyer, Gopa
    Apolo, Andrea Borghese
    Regazzi, Ashley Marie
    Garcia-Grossman, Ilana Rebecca
    Pendse, Deepa
    Ostrovnaya, Irina
    Chou, Joanne F.
    Bochner, Bernard
    Dalbagni, Guido
    Herr, Harry W.
    Milowsky, Matthew I.
    Bajorin, Dean F.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
12345